species are independent of the efficiency of excitation and detection of the emission, they can be more robust than fluorescence intensity measurements, particularly in complex scattering samples such as biological tissue 12. The application of fluorescence lifetime readouts to cartilage autofluorescence was reported in 2004 13 and subsequent work on ex vivo engineered cartilage tissue has shown the potential for autofluorescence lifetime (AFL) measurements to provide label-free readouts of cartilage degradation following specific treatments with collagenase, chondroitinase-ABC and ribose 14. We have previously reported that both the degradation of collagen and the removal of aggrecans from natural ex vivo cartilage are associated with a decrease in AFL of cartilage tissue following treatment with bacterial collagenase, human MMP-1 and, trypsin; and also aggrecanase induction by retinoic acid treatment of live cartilage 15. Collagen is a major contributor of cartilage autofluorescence through its intermolecular crosslinks 16,17. As the gaps between collagen fibrils are largely filled by aggrecans in cartilage tissue 4,5 , removal of aggrecan is likely to influence the chemical microenvironment of collagen crosslinks. This may explain why proteolytic removal of aggrecan from cartilage can reduce the AFL of cartilage collagen 15. Here we extend our previous work to evaluate the potential of AFL measurements to provide label-free readout of cartilage damage with a view to the development of a clinical instrument for the non-invasive monitoring of cartilage status. Specifically, this study focused on (1) how chemically-induced aggrecan depletion affects the AFL of intact murine, porcine and human cartilage; (2) whether AFL measurements can report local enzymatically-induced damage in the articular cartilage surface; (3) determining if AFL measurements can be used to detect natural erosion in human tibial plateau cartilage. Methods Materials. Bovine trypsin and retinoic acid were purchased from Sigma-Aldrich (Dorset, UK). Bacterial collagenase type 2 was purchased from Worthington Biochemical Corp (Lakewood, NJ, USA). Recombinant MMP-1 was expressed in E.coli, purified and activated as previously reported 18,19 .